Efficacy and Safety of Vaginal Radiofrequency for Vulvovaginal Atrophy in Breast Cancer Patients

This Phase III, randomized, balanced, parallel-group, multicenter trial aims to evaluate the effect of vaginal radiofrequency on symptoms of vaginal dryness at six months. The study compares vaginal radiofrequency treatment with non-hormonal hydration therapy in a population of patients undergoing adjuvant hormonal therapy with aromatase inhibitors, with or without LHRH agonists, for breast cancer. Patients will be randomly assigned to one of two parallel treatment groups until the six-month assessment: The first group will receive the reference treatment, which consists of local hydration u

Trial Details

NCT ID
NCT06900374
Phase
NA
Sponsor
Centre Oscar Lambret
Status
RECRUITING
Cancer Type
Inflammatory Breast Cancer Breast Cancer
Interventions
  • GynWave-360
  • Local hydratation
Locations (sample)
  • Lille, France|50.63391,3.05512

Key Eligibility Criteria

  • Patient over 40 years
  • Presenting disabling vaginal dryness symptoms despite well-administered local moisturizing treatment, attested by a vaginal dryness score ≥3
  • Patient undergoing adjuvant treatment for breast cancer
  • Patient treated with aromatase inhibitors +/- LHRH agonist for at least 3 months with a planned remaining duration of at least 12 months

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Inflammatory Breast Cancer Breast Cancer Trials on Trialify →